Nutanix
NTNX
73.42
+0.01
+0.01%
Nutanix
US · NTNX
#956 by market cap
Listed 2016
73.42
+0.01
+0.01%
Live - 5344 symbols - heartbeat 469s ago
· 2026-10-08 07:02
Pre-market
73.42
0.00%
After-hours
73.40
-0.03%
Overnight
73.37
-0.07%
- Market cap
- 19.87B
- P/E (TTM)i
- 14.20
- P/Bi
- 28.27
- EPSi
- 5.17
- Div yieldi
- 0.00%
- 52W posi
- 98%
Reader sentiment
Are you bullish or bearish on NTNX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.76, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +12.44% YoY
Margins
- Gross margin
- 86.80%
- Operating margin
- 9.60%
- Net margin
- 52.81%
Key ratios & quality
- Enterprise valuei
- 18.89B
- Altman Z-Scorei
- 2.76
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.24B | 1.31B | 1.39B | 1.58B | 1.86B | 2.15B | 2.54B | 2.85B |
| Gross profit | 932.02M | 1.02B | 1.10B | 1.26B | 1.53B | 1.82B | 2.20B | 2.48B |
| Selling & admin expenses | 1.03B | 1.30B | 1.21B | 1.15B | 1.16B | 1.18B | 1.29B | 1.41B |
| Research & development | 500.72M | 553.98M | 558.01M | 573.00M | 580.96M | 638.99M | 736.82M | 790.89M |
| Operating profit | -598.04M | -828.92M | -662.11M | -458.85M | -207.15M | 7.56M | 172.54M | 273.97M |
| Pretax profit | -613.06M | -855.22M | -1.02B | -779.68M | -233.59M | -101.32M | 211.65M | 327.11M |
| Tax | 8.12M | 17.66M | 18.49M | 19.26M | 20.98M | 23.46M | 23.28M | -1.18B |
| Net profit | -621.18M | -872.88M | -1.04B | -798.95M | -254.56M | -124.78M | 188.37M | 1.51B |
| Basic EPS | -3 | -4 | -5 | -4 | -1 | -1 | 1 | 6 |
| Diluted EPS | -3.43 | -4.48 | -5.02 | -3.62 | -1.09 | -0.51 | 0.65 | 5.17 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 638.98M | 653.27M | 670.58M | 722.83M | 703.07M | 757.08M |
| Gross profit | 555.99M | 569.43M | 583.11M | 631.55M | 610.79M | 651.35M |
| Selling & admin expenses | 320.85M | 344.83M | 346.29M | 345.07M | 344.09M | 376.57M |
| Research & development | 186.41M | 193.67M | 187.48M | 202.26M | 196.10M | 205.05M |
| Operating profit | 48.65M | 31.21M | 49.34M | 84.14M | 70.51M | 69.99M |
| Pretax profit | 64.60M | 45.14M | 65.57M | 97.51M | 81.31M | 82.72M |
| Tax | 1.24M | 6.49M | 3.48M | -5.52M | 9.23M | -1.19B |
| Net profit | 63.36M | 38.65M | 62.10M | 103.02M | 72.09M | 1.27B |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 5 |
| Diluted EPS | 0.22 | 0.13 | 0.21 | 0.36 | 0.25 | 4.34 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.28B | 1.09B | 1.56B | 1.66B | 1.86B | 1.48B | 2.59B | 3.03B |
| Cash & ST investments | 908.83M | 719.78M | 1.21B | 1.32B | 1.44B | 994.34M | 1.99B | 2.36B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 1.79B | 1.77B | 2.28B | 2.37B | 2.53B | 2.14B | 3.28B | 5.07B |
| Total current liabilities | 599.32M | 760.20M | 927.89M | 1.16B | 1.14B | 1.24B | 1.41B | 1.68B |
| Short-term debt | -- | 36.57M | 42.67M | 185.26M | 29.57M | 24.16M | 23.23M | 35.71M |
| Long-term debt | 458.91M | 490.22M | 1.06B | 1.16B | 1.22B | 570.07M | 1.34B | 1.35B |
| Total liabilities | 1,599,149,000.00 | 2,043,524,000.00 | 3,289,537,000.00 | 3,166,253,000.00 | 3,234,334,000.00 | 2,872,066,000.00 | 3,977,714,000.00 | 4,371,120,000.00 |
| Total equity | 186.89M | -274.98M | -1.01B | -800.50M | -707.42M | -728.15M | -694.52M | 702.57M |
| Retained earnings | -1.65B | -2.52B | -3.63B | -4.38B | -4.63B | -4.85B | -4.90B | -3.71B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 2.41B | 2.59B | 2.64B | 2.47B | 2.61B | 3.03B |
| Cash & ST investments | 1.88B | 1.99B | 2.06B | 1.87B | 2.02B | 2.36B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 3.10B | 3.28B | 3.32B | 3.28B | 3.42B | 5.07B |
| Total current liabilities | 1.28B | 1.41B | 1.40B | 1.49B | 1.47B | 1.68B |
| Short-term debt | 24.95M | 23.23M | 24.09M | 33.06M | 37.35M | 35.71M |
| Long-term debt | 1.34B | 1.34B | 1.35B | 1.35B | 1.35B | 1.35B |
| Total liabilities | 3,808,064,000.00 | 3,977,714,000.00 | 3,992,620,000.00 | 4,108,220,000.00 | 4,144,241,000.00 | 4,371,120,000.00 |
| Total equity | -711.43M | -694.52M | -668.63M | -831.29M | -725.61M | 702.57M |
| Retained earnings | -4.89B | -4.90B | -4.87B | -4.99B | -4.94B | -3.71B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 42.17M | -159.89M | -99.81M | 67.54M | 272.40M | 672.93M | 821.46M | 916.69M |
| Depreciation & amortization | 77.61M | 93.77M | 94.37M | 87.95M | 76.39M | 73.20M | 72.70M | 70.64M |
| Free cash flow | -76.28M | -249.37M | -158.46M | 18.49M | 207.00M | 597.68M | 750.17M | 840.68M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | -125.08M | -58.57M | 0 | -131.14M | -307.90M | -333.54M |
| Ending cash balance | 396.68M | 318.74M | 285.72M | 402.85M | 512.93M | 655.27M | 769.50M | 777.31M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 218.51M | 219.53M | 196.83M | 197.35M | 207.50M | 315.01M |
| Depreciation & amortization | 18.02M | 18.25M | 18.37M | 18.05M | 17.16M | 17.06M |
| Free cash flow | 203.41M | 207.78M | 174.51M | 191.42M | 197.18M | 277.57M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -37.76M | -50.04M | -50.23M | -332.87M | -50.14M | 99.70M |
| Ending cash balance | 872.60M | 769.50M | 780.42M | 603.40M | 718.81M | 777.31M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -241.86 | -- | -- | -- | -- | -- | -- | 37,460.21 |
| ROA %i | -36.69 | -49.11 | -51.12 | -34.35 | -10.41 | -5.34 | 6.94 | 36.06 |
| ROIC %i | -88.60 | -- | -- | -- | -- | -- | -- | 97.56 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -48.38 | -63.39 | -67.12 | -45.39 | -9.10 | 3.17 | 8.67 | 11.88 |
| FCF / sales %i | -- | -- | -- | 1.17 | 11.11 | 27.81 | 29.56 | 29.46 |
| Current ratioi | 2.13 | 1.44 | 1.68 | 1.43 | 1.64 | 1.19 | 1.83 | 1.80 |
| Quick ratioi | 1.93 | 1.29 | 1.51 | 1.25 | 1.41 | 0.99 | 1.66 | 1.58 |
| Debt / assetsi | 25.69 | 36.39 | 52.03 | 60.50 | 52.11 | 31.93 | 45.16 | 29.93 |
| LT debt / equityi | 245.55 | -- | -- | -- | -- | -- | -- | 211.09 |
| Interest coveragei | -- | -- | -11.71 | -11.81 | -2.64 | 0.40 | 26.26 | 28.30 |
| Revenue CAGR (3Y) %i | 34.91 | 15.63 | 6.47 | 8.54 | 12.52 | 15.51 | 17.09 | 15.27 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | 243.65 | 59.55 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | 37,460.21 |
| ROA %i | 0.80 | 6.94 | 8.01 | 8.53 | 8.47 | 36.06 |
| ROIC %i | -- | -- | -- | -- | -- | 97.56 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 7.10 | 8.67 | 9.59 | 10.60 | 10.97 | 11.88 |
| FCF / sales %i | 31.52 | 29.56 | 29.52 | 28.94 | 28.03 | 29.46 |
| Current ratioi | 1.88 | 1.83 | 1.89 | 1.65 | 1.78 | 1.80 |
| Quick ratioi | 1.69 | 1.66 | 1.72 | 1.44 | 1.55 | 1.58 |
| Debt / assetsi | 48.05 | 45.16 | 44.54 | 47.09 | 44.72 | 29.93 |
| LT debt / equityi | -- | -- | -- | -- | -- | 211.09 |
| Interest coveragei | 1.38 | 26.26 | 23.62 | 23.84 | 25.14 | 28.30 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Product is the largest reported line at 52.20% of revenue, across 2 reported segments.
- Support, maintenance and other services follows at 47.80%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Product52.20%
Support, maintenance and other services47.80%
Region
United States53.63%
Europe, the Middle East and Africa29.14%
Asia Pacific14.64%
Other Americas2.59%
Quote time 2026-10-08 07:02:42 · For reference only, not investment advice and not tailored to your situation.